New heart valve tested for High-Risk patients with leaky valve
NCT ID NCT07075861
Summary
This study is observing the safety and performance of the JenaValve Trilogy, a replacement heart valve delivered via a catheter, in people with a severe leaky aortic valve who are at high risk for open-heart surgery. It will follow 75 patients for up to 5 years to see how well the valve works and if there are any complications. The goal is to collect real-world data on this treatment option for a serious heart condition.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AORTIC REGURGITATION DISEASE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
IRCCS Policlinico San Donato
RECRUITINGSan Donato Milanese, Milano, 20097, Italy
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.